COSMOS Pharmaceutical Cor... (CSMYF)

AI Score

Unlock

46.06

-0.10 (-0.22%)

At close: Apr 24, 2025, 8:00 PM

COSMOS Pharmaceutical Income Statement

Financials in JPY. Fiscal year is June - May.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	May 31, 2024	Feb 29, 2024	Nov 30, 2023	Aug 31, 2023	May 31, 2023	Feb 28, 2023	Nov 30, 2022	Aug 31, 2022	May 31, 2022	Feb 28, 2022	Nov 30, 2021	Aug 31, 2021	May 31, 2021	Feb 28, 2021	Nov 30, 2020	Aug 31, 2020	May 31, 2020	Feb 29, 2020	Nov 30, 2019	Aug 31, 2019	May 31, 2019	Feb 28, 2019	Nov 30, 2018	Aug 31, 2018	May 31, 2018	Feb 28, 2018	Nov 30, 2017	Aug 31, 2017	May 31, 2017	Feb 28, 2017	Nov 30, 2016	Aug 31, 2016	May 31, 2016	Feb 29, 2016	Nov 30, 2015	Aug 31, 2015
Revenue	249.68B	238.88B	234.78B	241.65B	221.4B	202.29B	197.89B	206.12B	196.53B	187.75B	181.73B	189.41B	184.73B	177.52B	175.01B	189.16B	191.53B	167.61B	160.77B	164.5B	160.65B	152.12B	144.84B	153.53B	147.23B	139.94B	132.11B	138.73B	132.16B	123.52B	120.47B	126.58B	119.47B	111.22B	106.24B	110.33B
Cost of Revenue	201.04B	192.15B	188.86B	194.64B	176.99B	161.19B	156.97B	163.83B	156.53B	150.49B	145.52B	151.42B	148.44B	142.32B	139.63B	150.92B	154.77B	133.97B	129.23B	131.45B	128.69B	122.27B	115.52B	122.87B	117.7B	112.68B	106.28B	111.02B	106.56B	98.77B	96.23B	101.14B	96.24B	89.99B	85.31B	88.89B
Gross Profit	48.64B	46.73B	45.92B	47.01B	44.41B	41.1B	40.92B	42.29B	39.99B	37.26B	36.2B	37.99B	36.28B	35.2B	35.39B	38.24B	36.76B	33.64B	31.54B	33.05B	31.96B	29.85B	29.32B	30.66B	29.52B	27.26B	25.83B	27.7B	25.61B	24.75B	24.24B	25.44B	23.23B	21.24B	20.94B	21.45B
Operating Income	7.76B	7.9B	6.85B	8.99B	7.96B	6.78B	6.49B	8.9B	7.9B	6.92B	6.42B	8.56B	7.14B	7.72B	7.64B	10.65B	9.66B	7.47B	4.94B	7.02B	6.75B	5.7B	5.33B	7B	6.97B	5.49B	4.03B	6.26B	4.86B	5.49B	5.08B	6.8B	5.23B	4.27B	4.16B	5B
Interest Income	11M	12M	11M	10M	12M	12M	12M	11M	14M	13M	13M	12M	15M	14M	14M	14M	17M	16M	16M	16M	18M	18M	19M	17M	19M	20M	20M	19M	21M	22M	21M	21M	24M	22M	23M	22M
Pretax Income	7.78B	8.73B	7.58B	9.64B	8.54B	7.47B	7.18B	9.58B	8.65B	7.76B	7.42B	9.21B	6.89B	12.48B	8.24B	10.98B	9.41B	8.05B	5.52B	7.43B	7.65B	6.22B	6.09B	7.18B	7.61B	6.05B	4.67B	6.83B	5.49B	6.29B	6.55B	7.41B	5.15B	5.11B	4.63B	5.6B
Net Income	7.1B	5.77B	5.08B	6.51B	7.51B	4.98B	4.82B	6.48B	6.7B	5.21B	5B	6.24B	5.58B	8.51B	5.58B	7.49B	7.2B	5.47B	3.72B	5.05B	5.98B	4.2B	4.12B	4.88B	5.76B	4.09B	3.14B	4.64B	5.64B	3.9B	4.07B	4.61B	3.23B	3.06B	2.77B	3.37B
Selling & General & Admin	1.93B	38.83B	39.07B	38.02B	36.45B	34.31B	34.43B	33.39B	32.1B	30.34B	29.78B	29.43B	29.15B	27.49B	27.75B	27.58B	14.56B	26.17B	26.6B	26.02B	13.25B	24.15B	23.98B	23.66B	11.67B	21.77B	21.8B	21.44B	11.04B	19.26B	19.16B	18.64B	9.24B	16.97B	16.78B	16.45B
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	40.88B	672M	807M	715M	735M	710M	789M	726M	863M	687M	771M	745M	839M	598M	694M	610M	776M	624M	637M	509M	857M	491M	614M	559M	637M	575M	702M	601M	620M	577M	677M	492M	535M	492M	511M	505M
Operating Expenses	40.88B	38.83B	39.07B	38.02B	36.45B	34.31B	34.43B	33.39B	32.1B	30.34B	29.78B	29.43B	29.15B	27.49B	27.75B	27.58B	27.1B	26.17B	26.6B	26.02B	25.21B	24.15B	23.98B	23.66B	22.55B	21.77B	21.8B	21.44B	20.75B	19.26B	19.16B	18.64B	18B	16.97B	16.78B	16.45B
Interest Expense	46M	18M	17M	18M	17M	11M	11M	12M	12M	13M	14M	13M	14M	15M	16M	15M	17M	17M	17M	18M	19M	19M	19M	20M	22M	21M	22M	23M	24M	24M	25M	25M	26M	27M	23M	15M
Selling & Marketing Expenses	1.81B	n/a	n/a	n/a	1.65B	n/a	n/a	n/a	1.63B	n/a	n/a	n/a	2.78B	n/a	n/a	n/a	4.27B	n/a	n/a	n/a	3.77B	n/a	n/a	n/a	1.84B	n/a	n/a	n/a	1.81B	n/a	n/a	n/a	1.69B	n/a	n/a	n/a
Cost & Expenses	241.91B	230.98B	227.93B	232.66B	213.43B	195.5B	191.41B	197.22B	188.63B	180.83B	175.31B	180.85B	177.59B	169.8B	167.38B	178.5B	181.87B	160.14B	155.83B	157.48B	153.9B	146.42B	139.51B	146.54B	140.26B	134.45B	128.07B	132.47B	127.3B	118.03B	115.39B	119.78B	114.25B	106.95B	102.09B	105.34B
Income Tax Expense	681M	2.96B	2.5B	3.13B	1.03B	2.48B	2.37B	3.1B	1.95B	2.55B	2.42B	2.97B	1.31B	3.98B	2.66B	3.49B	2.21B	2.58B	1.79B	2.38B	1.68B	2.01B	1.97B	2.3B	1.85B	1.96B	1.53B	2.19B	-149M	2.39B	2.48B	2.8B	1.92B	2.05B	1.86B	2.23B
Shares Outstanding (Basic)	79.26M	39.63M	39.62M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M
Shares Outstanding (Diluted)	79.26M	39.63M	39.62M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M	39.6M
EPS (Basic)	89.54	145.60	128.20	164.35	189.75	125.86	121.67	163.68	169.20	131.57	126.32	157.66	140.79	214.88	140.96	189.15	181.72	138.08	93.99	127.50	150.96	106.11	104.04	123.36	145.43	103.36	79.37	117.12	142.33	98.39	102.75	116.52	81.64	77.40	69.88	85.10
EPS (Diluted)	89.54	145.60	128.20	164.35	189.75	125.86	121.67	163.68	169.20	131.57	126.32	157.66	140.79	214.88	140.96	189.15	181.72	138.08	93.99	127.50	150.96	106.11	104.04	123.36	145.43	103.36	79.37	117.12	142.33	98.39	102.75	116.52	81.64	77.40	69.88	85.10
EBITDA	7.82B	12.99B	7.59B	13.33B	12.3B	10.56B	10.61B	12.68B	11.68B	10.36B	9.97B	12B	10.58B	12.5B	10.99B	14.05B	13.05B	8.07B	5.53B	10.26B	7.67B	6.24B	6.11B	9.97B	7.63B	6.07B	4.7B	6.86B	5.51B	6.31B	6.58B	7.44B	5.78B	5.14B	4.66B	5.62B
EBIT	7.82B	8.75B	7.59B	9.65B	8.56B	7.48B	7.19B	9.59B	8.66B	7.77B	7.44B	9.23B	6.91B	12.5B	8.25B	11B	9.42B	8.07B	5.53B	7.45B	7.67B	6.24B	6.11B	7.21B	7.63B	6.07B	4.7B	6.86B	5.51B	6.31B	6.58B	7.44B	5.18B	5.14B	4.66B	5.62B
Depreciation & Amortization	60M	5.09B	819M	4.59B	4.7B	4.43B	4.23B	4.01B	4.15B	3.87B	3.64B	3.45B	3.61B	3.39B	3.36B	3.39B	3.39B	3.24B	3.3B	3.24B	3.24B	2.97B	3.12B	2.97B	655M	597M	719M	621M	643M	598M	699M	512M	557M	514M	532M	529M